Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Caron

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 TrialPaul Toren, Azik Hoffman, Keyue Ding, et al.
British Journal of Cancer|April 8, 2021
Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progressionJean-Philippe Emond, Louis Lacombe, Patrick Caron, et al.
British Journal of Cancer|November 8, 2022
Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancerMichèle Rouleau, Flora Nguyen Van Long, Véronique Turcotte, et al.
The Journal of Urology|December 18, 2019
Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary TherapyFrédéric Pouliot, Mélanie Rouleau, Bertrand Neveu, et al.
European Urology|July 29, 2015
The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer ProgressionAnaïs Belledant, Hélène Hovington, Luciana Garcia, et al.
Clinical and Translational Medicine|December 1, 2023
Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survivalFlora Nguyen Van Long, Délya Valcourt-Gendron, Patrick Caron, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2010
Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathwaysJohanie Lépine, Etienne Audet-Walsh, Jean Grégoire, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liverHugo Girard, Jean Thibaudeau, Michael H Court, et al.
The Journal of Clinical Endocrinology and Metabolism|July 8, 2011
Deletions of the androgen-metabolizing UGT2B genes have an effect on circulating steroid levels and biochemical recurrence after radical prostatectomy in localized prostate cancerGeneviève Nadeau, Judith Bellemare, Étienne Audet-Walsh, et al.
The Journal of Biological Chemistry|November 6, 2009
The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liverJocelyn Trottier, Diala El Husseini, Martin Perreault, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Serum Sex Steroids as Prognostic Biomarkers in Patients Receiving Androgen Deprivation Therapy for Recurrent Prostate Cancer: A <i>Post Hoc</i> Analysis of the PR.7 TrialPaul Toren, Azik Hoffman, Keyue Ding, et al.
British Journal of Cancer|April 8, 2021
Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progressionJean-Philippe Emond, Louis Lacombe, Patrick Caron, et al.
British Journal of Cancer|November 8, 2022
Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancerMichèle Rouleau, Flora Nguyen Van Long, Véronique Turcotte, et al.
The Journal of Urology|December 18, 2019
Extragonadal Steroids Contribute Significantly to Androgen Receptor Activity and Development of Castration Resistance in Recurrent Prostate Cancer after Primary TherapyFrédéric Pouliot, Mélanie Rouleau, Bertrand Neveu, et al.
European Urology|July 29, 2015
The UGT2B28 Sex-steroid Inactivation Pathway Is a Regulator of Steroidogenesis and Modifies the Risk of Prostate Cancer ProgressionAnaïs Belledant, Hélène Hovington, Luciana Garcia, et al.
Clinical and Translational Medicine|December 1, 2023
Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survivalFlora Nguyen Van Long, Délya Valcourt-Gendron, Patrick Caron, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2010
Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathwaysJohanie Lépine, Etienne Audet-Walsh, Jean Grégoire, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liverHugo Girard, Jean Thibaudeau, Michael H Court, et al.
The Journal of Clinical Endocrinology and Metabolism|July 8, 2011
Deletions of the androgen-metabolizing UGT2B genes have an effect on circulating steroid levels and biochemical recurrence after radical prostatectomy in localized prostate cancerGeneviève Nadeau, Judith Bellemare, Étienne Audet-Walsh, et al.
The Journal of Biological Chemistry|November 6, 2009
The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liverJocelyn Trottier, Diala El Husseini, Martin Perreault, et al.
Pageof 10